Background Skeletal metastasis is a common metastatic event for several carcinomas, and the treat-ment for skeletal metastasis of unknown primary (SMUP) are a critical issue in cancer ther-apy. Making a diagnosis of the primary site is the most crucial step in the treatment of SMUP; however, the procedures are sometimes difficult and time-consuming, and the pri-mary site often remains unknown. Therefore, to establish optimal diagnostic strategies and elucidate the overall survival rates of SMUP, we conducted this retrospective study. Methods We retrospectively analyzed the clinical data for 286 SMUP cases from a total of 2,641 patients with skeletal metastases who were treated between 2002 and 2014 at our initiations. Results The primary si...
Background: Bones are one of the most common metastatic sites for solid malignancies. Bone metastase...
Introduction: The skeletal system is one of the most common distant sites of metastatic non-small ce...
Background: This study evaluated the incidence of de novo bone metastasis across all primary cancer ...
<div><p>Background</p><p>Skeletal metastasis is a common metastatic event for several carcinomas, an...
Skeletal metastasis is a common metastatic event for several carcinomas, and the treatment for skele...
Abstract Metastases are the most common malignancies involving bone; breast, prostate, lung and thyr...
Skeletal metastases of unknown primary (SMUP) represent a clinical challenge in dealing with patient...
CONTEXT AND AIM: The skeleton is a frequent site for metastasis in patients with breast, lung, and p...
Bone scintigraphies are widely applied for detecting bone metastases. The aim of this study was to i...
Background: Skeletal metastases are the most common malignant tumor in bone. Certain types of cancer...
ABSTRACT Objectives: To determine the role of immunohistochemistry in identifying the primary site ...
Objective: The aim of this article is to provide additional documentation of bone metastases to help...
Five-year survival rates for most patients with localized cancers have risen consistently over the p...
Background: Cancer of unknown primary site (CUP) is considered an aggressive metastatic disease but ...
The last report of the World Health Organization (WHO) stated that approximately four million people...
Background: Bones are one of the most common metastatic sites for solid malignancies. Bone metastase...
Introduction: The skeletal system is one of the most common distant sites of metastatic non-small ce...
Background: This study evaluated the incidence of de novo bone metastasis across all primary cancer ...
<div><p>Background</p><p>Skeletal metastasis is a common metastatic event for several carcinomas, an...
Skeletal metastasis is a common metastatic event for several carcinomas, and the treatment for skele...
Abstract Metastases are the most common malignancies involving bone; breast, prostate, lung and thyr...
Skeletal metastases of unknown primary (SMUP) represent a clinical challenge in dealing with patient...
CONTEXT AND AIM: The skeleton is a frequent site for metastasis in patients with breast, lung, and p...
Bone scintigraphies are widely applied for detecting bone metastases. The aim of this study was to i...
Background: Skeletal metastases are the most common malignant tumor in bone. Certain types of cancer...
ABSTRACT Objectives: To determine the role of immunohistochemistry in identifying the primary site ...
Objective: The aim of this article is to provide additional documentation of bone metastases to help...
Five-year survival rates for most patients with localized cancers have risen consistently over the p...
Background: Cancer of unknown primary site (CUP) is considered an aggressive metastatic disease but ...
The last report of the World Health Organization (WHO) stated that approximately four million people...
Background: Bones are one of the most common metastatic sites for solid malignancies. Bone metastase...
Introduction: The skeletal system is one of the most common distant sites of metastatic non-small ce...
Background: This study evaluated the incidence of de novo bone metastasis across all primary cancer ...